Cost-utility analysis and eligibility of dapagliflozin for patients with heart failure across the whole spectrum of ejection fraction

被引：0
|
作者：
Kim, E. S. [1 ]
Park, S. K. [2 ]
Youn, J. C. [3 ]
Lee, H. Y. [4 ]
Kim, M. S. [5 ]
Choi, J. O. [6 ]
Kang, S. M. [7 ]
Yoo, B. S. [8 ]
Choi, D. J. [9 ]
Oh, B. H. [10 ]
Baek, S. H. [3 ]
机构：
[1] Korea Adv Inst Sci & Technol, Daejeon, South Korea
[2] Catholic Univ Korea, Coll Pharm, Bucheon, South Korea
[3] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[5] Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[6] Samsung Med Ctr, Dept Internal Med, Seoul, South Korea
[7] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[8] Wonju Severance Christian Hosp, Dept Internal Med, Wonju, South Korea
[9] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[10] Mediplex Sejong Hosp, Dept Internal Med, Incheon, South Korea
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [31] Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
    Selvaraj, Senthil
    Patel, Shachi
    Sauer, Andrew J.
    Mcgarrah, Robert W.
    Jones, Philip
    Kwee, Lydia Coulter
    Windsor, Sheryl L.
    Ilkayeva, Olga
    Muehlbauer, Michael J.
    Newgard, Christopher B.
    Borlaug, Barry A.
    Kitzman, Dalane W.
    Shah, Sanjiv J.
    Margulies, Kenneth B.
    Husain, Mansoor
    Inzucchi, Silvio E.
    Mcguire, Darren K.
    Lanfear, David E.
    Javaheri, Ali
    Umpierrez, Guillermo
    Mentz, Robert J.
    Sharma, Kavita
    Kosiborod, Mikhail N.
    Shah, Svati H.
    CIRCULATION-HEART FAILURE, 2024, 17 (11)
  • [32] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction REPLY
    McMurray, John J. V.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 973 - 973
  • [33] Dapagliflozin in Heart Failure with Preserved Ejection Fraction
    Zweck, Elric
    Westenfeld, Ralf
    Redfors, Bjorn
    Omerovic, Elmir
    Weir, Robin A. P.
    Gabrielli, Domenico
    Oliva, Fabrizio
    Zuccala, Giuseppe
    Solomon, Scott D.
    Vaduganathan, Muthiah
    McMurray, John J. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 286 - 286
  • [34] Cost-utility analysis of add-on Qili Qiangxin capsules in chronic heart failure with reduced ejection fraction in China
    Wang, Lu
    Wang, Yinglin
    Zhao, Quan
    ESC HEART FAILURE, 2025,
  • [35] Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis
    Naves, Marcio Coutinho Xavier
    Amato, Angelica Amorim
    Zimmermann, Ivan Ricardo
    Peixoto, Henry Maia
    LANCET REGIONAL HEALTH-AMERICAS, 2025, 42
  • [36] Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
    Isaza, Nicolas
    Calvachi, Paola
    Raber, Inbar
    Liu, Chia-Liang
    Bellows, Brandon K.
    Hernandez, Inmaculada
    Shen, Changyu
    Gavin, Michael C.
    Garan, A. Reshad
    Kazi, Dhruv S.
    JAMA NETWORK OPEN, 2021, 4 (07) : E2114501
  • [37] COMPARATIVE COST EFFECTIVENESS OF DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Gravlee, E.
    Prajapati, P.
    VALUE IN HEALTH, 2022, 25 (07) : S409 - S410
  • [38] Clinical Phenotypes of Heart Failure across the spectrum of Ejection Fraction: A Cluster Analysis
    Gouda, Pishoy
    Alemayehu, Wendimagegn
    Rathwell, Sarah
    Paterson, D. Ian
    Anderson, Todd
    Dyck, Jason R. B.
    Howlett, Jonathan G.
    Oudit, Gavin Y.
    McAlister, Finlay A.
    Thompson, Richard B.
    Ezekowitz, Justin
    Alberta HEART Study Investigators
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (11)
  • [39] Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea
    Park, Sun-Kyeong
    Hong, Sung-Hyun
    Kim, HyoJin
    Kim, Sungju
    Lee, Eui-Kyung
    CLINICAL THERAPEUTICS, 2019, 41 (06) : 1066 - 1079
  • [40] Anxiety or depression in heart failure across the ejection fraction spectrum
    Settergren, C.
    Benson, L.
    Dahlstrom, U.
    Thorvaldsen, T.
    Savarese, G.
    Lund, L. H.
    Shahim, B.
    EUROPEAN HEART JOURNAL, 2024, 45
12345